SCHOLARSHIPS FOR PATIENTS WITH RARE DISEASE: DUBLIN–( BUSINESS WIRE )–Horizon Therapeutics plc (Nasdaq: HZNP) today announced a $1 million commitment over five years to establish the #RAREis scholarship, a program that will be made available by the EveryLife Foundation for Rare Diseases. The #RAREis scholarship will support the pursuit of life enrichment activities for adults […]
Click here to view original web page at www.businesswire.com